治疗严重喘的特泽佩卢马布:一种针对多种疾病途径和患者类型的药物
Reynold Panettieri1, Njira Lugogo2, Jonathan Corren3
1Rutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, USA.
Journal of asthma and allergy
|March 25, 2024
概括
一种新的生物疗法Tezepelumab显著减少了严重喘表型中的喘恶化. 这种治疗为患有无法控制的严重喘的患者提供了广泛的抗炎作用.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘影响着全球数以百万计的人,通常是标准疗法无法控制的.
- 了解喘异质性和炎症途径对于开发有效治疗方法至关重要.
- 高剂量的吸入性皮质类固醇和控制药物对于许多严重喘患者来说是不够的.
研究的目的:
- 描述tezepelumab在严重喘中的抗炎作用和疗效.
- 为了评估tezepelumab在各种严重喘表型中的有效性.
- 为突出tezepelumab作为一种广泛作用的生物疗法的潜力.
主要方法:
- 临床研究评估tezepelumab在患有严重喘的患者中.
- 年化喘恶化率 (AAER) 与安慰剂的评估.
- 对不同喘现象型的疗效分析,包括异性喘,过敏性喘,低2型喘和口服皮质类固醇依赖性喘.
主要成果:
- 与安慰剂相比,Tezepelumab在严重喘表型中减少了31-71%的AAER.
- 观察到需要住院或急诊室访问的恶化症的显著减少.
- 疗效因表型而异,在酸性喘和过敏性喘中具有显著的益处.
结论:
- 佩鲁马布在减少严重喘表型中的恶化方面表现出广泛的有效性.
- 这种单克隆抗体向胸膜 stromal lymphopoietin 提供了一种新的治疗方法.
- 在严重的不受控制的喘中,Tezepelumab可能会提供更广泛的呼吸道炎症调节.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
01:20Asthma: Pathogenesis and Management
394
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
261
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
261
01:17Drugs Used in Lower Respiratory Disorders: Overview
437
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
437